RS17091891 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (11)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Familial combined hyperlipidemia defined by Dutch criteria | T | OR: 0.31 | 3E-64 | PubMed |
| Type 2 diabetes mellitus or coronary artery disease (pleiotropy) | — | — | 2E-21 | PubMed |
| Familial combined hyperlipidemia defined by Goldstein criteria | T | OR: 0.51 | 2E-17 | PubMed |
| Coronary artery disease | T | β: 0.059 | 5E-14 | PubMed |
| total cholesterol (minimum, inv-norm transformed) | T | β: 0.023 | 5E-13 | PubMed |
| Coronary artery disease or fibrinogen levels (pleiotropy) | — | — | 3E-12 | PubMed |
| Coronary artery disease or factor XI levels (pleiotropy) | — | — | 5E-11 | PubMed |
| Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | — | — | 7E-11 | PubMed |
| Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | — | — | 7E-11 | PubMed |
| Type 2 diabetes | C | β: 0.042 | 3E-9 | PubMed |
| Palmitoyl sphingomyelin (d18:1/16:0) levels | T | β: 0.089 | 9E-9 | PubMed |